RINTX | VTSNX | RINTX / VTSNX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 14 years | - |
Gain YTD | 1.386 | 0.900 | 154% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.01B | 432B | 0% |
Annual Yield % from dividends | 2.07 | 3.29 | 63% |
Returns for 1 year | 7.17 | 7.06 | 102% |
Returns for 3 years | 2.68 | -3.19 | -84% |
Returns for 5 years | 18.64 | 9.62 | 194% |
Returns for 10 years | 31.48 | 33.23 | 95% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
UCC | 53.72 | 1.39 | +2.65% |
ProShares Ultra Consumer Discretionary | |||
FREL | 27.19 | N/A | N/A |
Fidelity MSCI Real Estate ETF | |||
XHYI | 37.99 | N/A | N/A |
BondBloxx US High Yield Indstrl Sctr ETF | |||
IEI | 115.56 | -0.05 | -0.04% |
iShares 3-7 Year Treasury Bond ETF | |||
PJP | 82.62 | -0.32 | -0.39% |
Invesco Pharmaceuticals ETF |